$WFRD
Weatherford International plc

2024 Q3 Form 10-Q Financial Statement

#000160392324000110 Filed on July 24, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $1.409B $1.405B
YoY Change 7.31% 10.28%
Cost Of Revenue $917.0M $891.0M
YoY Change 6.75% 5.19%
Gross Profit $492.0M $514.0M
YoY Change 8.37% 20.37%
Gross Profit Margin 34.92% 36.58%
Selling, General & Admin $203.0M $216.0M
YoY Change -3.79% 36.71%
% of Gross Profit 41.26% 42.02%
Research & Development $33.00M $31.00M
YoY Change 10.0% 14.81%
% of Gross Profit 6.71% 6.03%
Depreciation & Amortization $89.00M $86.00M
YoY Change 7.23% 6.17%
% of Gross Profit 18.09% 16.73%
Operating Expenses $236.0M $247.0M
YoY Change -2.07% 9.78%
Operating Profit $243.0M $264.0M
YoY Change 11.47% 30.69%
Interest Expense -$24.00M -$24.00M
YoY Change -20.0% -72.73%
% of Operating Profit -9.88% -9.09%
Other Income/Expense, Net -$41.00M -$20.00M
YoY Change 70.83% -48.72%
Pretax Income $178.0M $210.0M
YoY Change 8.54% 183.78%
Income Tax $12.00M $73.00M
% Of Pretax Income 6.74% 34.76%
Net Earnings $157.0M $125.0M
YoY Change 27.64% 52.44%
Net Earnings / Revenue 11.14% 8.9%
Basic Earnings Per Share $2.14 $1.71
Diluted Earnings Per Share $2.06 $1.66
COMMON SHARES
Basic Shares Outstanding 73.16M shares 73.15M shares
Diluted Shares Outstanding 75.20M shares 75.30M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $920.0M $862.0M
YoY Change 9.65% 9.53%
Cash & Equivalents $920.0M $862.0M
Short-Term Investments
Other Short-Term Assets $272.0M $239.0M
YoY Change 14.77% -23.64%
Inventory $919.0M $884.0M
Prepaid Expenses
Receivables $1.231B $1.319B
Other Receivables $0.00 $0.00
Total Short-Term Assets $3.400B $3.362B
YoY Change 5.59% 13.16%
LONG-TERM ASSETS
Property, Plant & Equipment $1.050B $1.007B
YoY Change 13.88% -2.52%
Goodwill
YoY Change
Intangibles $356.0M $384.0M
YoY Change -11.88% -12.73%
Long-Term Investments
YoY Change
Other Assets $249.0M $220.0M
YoY Change 14.75% 24.29%
Total Long-Term Assets $1.788B $1.749B
YoY Change 6.75% 4.29%
TOTAL ASSETS
Total Short-Term Assets $3.400B $3.362B
Total Long-Term Assets $1.788B $1.749B
Total Assets $5.188B $5.111B
YoY Change 5.99% 9.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $723.0M $771.0M
YoY Change 16.61% 53.59%
Accrued Expenses $374.0M $339.0M
YoY Change -2.09% 1.19%
Deferred Revenue $32.00M $35.00M
YoY Change -30.43% -2.78%
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $21.00M $20.00M
YoY Change -76.92% -39.39%
Total Short-Term Liabilities $1.667B $1.691B
YoY Change -3.7% 15.51%
LONG-TERM LIABILITIES
Long-Term Debt $1.627B $1.628B
YoY Change -12.71% -18.31%
Other Long-Term Liabilities $151.0M $147.0M
YoY Change 3.42% -71.68%
Total Long-Term Liabilities $151.0M $147.0M
YoY Change 3.42% -94.15%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.667B $1.691B
Total Long-Term Liabilities $151.0M $147.0M
Total Liabilities $3.832B $3.871B
YoY Change -7.26% -3.3%
SHAREHOLDERS EQUITY
Retained Earnings -$1.579B -$1.717B
YoY Change -24.59% -22.55%
Common Stock $2.956B $2.997B
YoY Change 1.93% 3.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.345B $1.228B
YoY Change
Total Liabilities & Shareholders Equity $5.188B $5.111B
YoY Change 5.99% 9.96%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $157.0M $125.0M
YoY Change 27.64% 52.44%
Depreciation, Depletion And Amortization $89.00M $86.00M
YoY Change 7.23% 6.17%
Cash From Operating Activities $262.0M $150.0M
YoY Change 52.33% -25.37%
INVESTING ACTIVITIES
Capital Expenditures $78.00M $62.00M
YoY Change 85.71% 72.22%
Acquisitions
YoY Change
Other Investing Activities -$14.00M $1.000M
YoY Change -333.33% -104.55%
Cash From Investing Activities -$92.00M -$61.00M
YoY Change 155.56% 5.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -89.00M -102.0M
YoY Change -2.2% -40.0%
NET CHANGE
Cash From Operating Activities 262.0M 150.0M
Cash From Investing Activities -92.00M -61.00M
Cash From Financing Activities -89.00M -102.0M
Net Change In Cash 81.00M -13.00M
YoY Change 80.0% -51.85%
FREE CASH FLOW
Cash From Operating Activities $262.0M $150.0M
Capital Expenditures $78.00M $62.00M
Free Cash Flow $184.0M $88.00M
YoY Change 41.54% -46.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
72100000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
72100000 shares
us-gaap Inventory Write Down
InventoryWriteDown
11000000 usd
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
7000000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-53000000 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
17000000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
83000000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
75000000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
44000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
281000000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
121000000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
18000000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
40000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-7000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-297000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-56000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-190000000 usd
CY2024Q2 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
39000000 usd
CY2023Q2 us-gaap Revenues
Revenues
1274000000 usd
CY2024Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
86000000 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
81000000 usd
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12000000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8000000 usd
CY2024Q2 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
3000000 usd
CY2023Q2 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
1000000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
264000000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
201000000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
68000000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-88000000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-72000000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-32000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
285000000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
100000000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
14000000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
50000000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
110000000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
53000000 usd
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
73200000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
73200000 shares
us-gaap Inventory Write Down
InventoryWriteDown
15000000 usd
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
32000000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
27000000 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
25000000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
73000000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
92000000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
79000000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
36000000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
4000000 usd
us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
41000000 usd
us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
33000000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
7000000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
8000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-115000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-122000000 usd
us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
259000000 usd
us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
230000000 usd
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
9000000 usd
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
6000000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9000000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
54000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-12000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-289000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-20000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-143000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1063000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1112000000 usd
us-gaap Interest Paid Net
InterestPaidNet
81000000 usd
us-gaap Interest Paid Net
InterestPaidNet
95000000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
89000000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
64000000 usd
us-gaap Stock Issued1
StockIssued1
75000000 usd
us-gaap Stock Issued1
StockIssued1
0 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2024Q2 us-gaap Revenues
Revenues
1405000000 usd
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
73000000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1405000000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1319000000 usd
CY2024Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
53000000 usd
CY2024Q2 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
28000000 usd
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
35000000 usd
CY2024Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3000000 usd
CY2024Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
114000000 usd
CY2024Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
750000000 usd
CY2024Q2 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
134000000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
884000000 usd
CY2024Q2 us-gaap Inventory Write Down
InventoryWriteDown
9000000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
718000000 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
384000000 usd
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
41000000 usd
CY2024Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
20000000 usd
CY2024Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
20000000 usd
CY2024Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
40000000 usd
CY2024Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
1628000000 usd
CY2023Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
376000000 usd
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
73200000 shares
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
922000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
123000000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-24000000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
75000000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1100000000 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
137000000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
12000000 usd
CY2024Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
9000000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1240000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
551000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
81000000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
6000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3000000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
586000000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
90000000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
6000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-10000000 usd
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-24000000 usd
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-7000000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
125000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
82000000 usd
us-gaap Net Income Loss
NetIncomeLoss
237000000 usd
us-gaap Net Income Loss
NetIncomeLoss
154000000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73200000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72100000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73100000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72100000 shares
CY2024Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2100000 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1300000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1900000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1300000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75300000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
73400000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75000000.0 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
73400000 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.71
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.25
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.14
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.66
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.11
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
500000 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8800000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
500000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8700000 shares
CY2019Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
7800000 shares
CY2019Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
99.96
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
73000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
132000000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-16000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22000000 usd
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
20000000 usd
CY2024Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
278000000 usd
CY2024Q2 us-gaap Decrease In Unrecognized Tax Benefits Is Reasonably Possible
DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
13000000 usd
CY2023Q4 us-gaap Proceeds From Collection Of Loans Receivable
ProceedsFromCollectionOfLoansReceivable
140000000 usd
CY2024Q1 us-gaap Proceeds From Collection Of Loans Receivable
ProceedsFromCollectionOfLoansReceivable
142000000 usd
CY2024Q1 us-gaap Proceeds From Collection Of Loans Receivable
ProceedsFromCollectionOfLoansReceivable
142000000 usd
CY2024Q2 wfrd Derivative Percentage Higher Than Official Exchange Rate
DerivativePercentageHigherThanOfficialExchangeRate
0.26
CY2023Q2 wfrd Derivative Percentage Higher Than Official Exchange Rate
DerivativePercentageHigherThanOfficialExchangeRate
1.06
CY2024Q2 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
-10000000 usd
CY2023Q2 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
-57000000 usd
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
0001603923-24-000110-index-headers.html Edgar Link pending
0001603923-24-000110-index.html Edgar Link pending
0001603923-24-000110.txt Edgar Link pending
0001603923-24-000110-xbrl.zip Edgar Link pending
a2024-q2ex311ceo302cert.htm Edgar Link pending
a2024-q2ex312cfo302cert.htm Edgar Link pending
a2024-q2ex321ceo906cert.htm Edgar Link pending
a2024-q2ex322cfo906cert.htm Edgar Link pending
exhibit103-wfrdxseventhame.htm Edgar Link pending
exhibit104-secondamendedan.htm Edgar Link pending
exhibit105-weatherfordxmod.htm Edgar Link pending
exhibit106-weatherfordxmod.htm Edgar Link pending
exhibit107-weatherfordxmod.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wfrd-20240630.htm Edgar Link pending
wfrd-20240630.xsd Edgar Link pending
wfrd-20240630_cal.xml Edgar Link unprocessable
wfrd-20240630_def.xml Edgar Link unprocessable
wfrd-20240630_lab.xml Edgar Link unprocessable
wfrd-20240630_pre.xml Edgar Link unprocessable
wfrd-20240630_htm.xml Edgar Link completed